Advertisement

Cardiovascular Intervention and Therapeutics

, Volume 33, Issue 2, pp 175–177 | Cite as

Early disarticulation of a bioresorbable vascular scaffold: an underreported consequence of repeat imaging

  • Joel P. Giblett
  • Adam J. Brown
  • Stephen P. Hoole
  • Nick E. J. West
Images in Cardiovascular Intervention

Notes

Compliance with ethical standards

Conflict of interest

Dr. West has acted as a consultant for Abbott Vascular. Dr. Hoole has acted as a consultant for St. Jude Medical and Abbott Vascular. All other authors have no conflicts of interest to declare.

Supplementary material

Supplementary material 1 (MPG 140492 kb)

References

  1. 1.
    Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301–12.CrossRefPubMedGoogle Scholar
  2. 2.
    Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54(21):1924–31.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2017

Authors and Affiliations

  • Joel P. Giblett
    • 1
    • 2
  • Adam J. Brown
    • 1
    • 2
  • Stephen P. Hoole
    • 1
  • Nick E. J. West
    • 1
  1. 1.Department of Interventional CardiologyPapworth HospitalCambridgeUK
  2. 2.Division of Cardiovascular MedicineUniversity of CambridgeCambridgeUK

Personalised recommendations